#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Round cell liposarcoma Macular telangiectasia Mucopolysaccharidosis I Haemophagocytic lymphohistiocytosis Non-Hodgkin's lymphoma Hereditary optic atrophy Bronchiolitis Inborn error of metabolism PIK3CA-activated mutation Congenital aplastic anaemia Congenital generalised lipodystrophy Brain injury Diabetes insipidus Polycystic liver disease Glycogen storage disease type II More trials…

    Learn about Rare Diseases

    Hereditary optic atrophy – Diagnostics Pleural mesothelioma malignant – Life with Disease Ehlers-Danlos syndrome – Diagnostics Medulloblastoma recurrent – Basic Information Behcet’s syndrome Factor IX deficiency – Basic Information Idiopathic pulmonary fibrosis – Diagnostics Mantle cell lymphoma stage IV IgA nephropathy – Basic Information Phenylketonuria – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Simeticone Garetosmab Gandotinib Vortioxetine Dexamethasone Ph. Eur. Cefixime Tretinoin Tolinapant Lactate PRILOCAINE HYDROCHLORIDE 204-NETU Vsf1.01 2,4 DICHLOROBENZYL ALCOHOL Suvecaltamide Gebasaxturev ALXN1920 Clotrimazole Glofitamab Pralsetinib Loncastuximab Tesirine Cabazitaxel More therapies…

    Learn about Your Condition

    Scoliosis Type IIa hyperlipidaemia Testicular germ cell tumour Autism spectrum disorder Tachypnoea Breast cancer stage II Axial spondyloarthritis Tympanic membrane perforation Immunosuppression Medullary thyroid cancer Mechanical ventilation Immune system disorder Milk allergy Cortical dysplasia Transient ischaemic attack More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bacterial Infections and Mycoses

  • Study on Reducing Prosthetic Joint Infection in Hip Replacement Patients Using Vancomycin, Tobramycin, and Saline-Infused Bone Graft

    Recruiting

    2 1 1
    Investigated Diseases:
    • Medical device site joint infection
    Investigated Drugs:
    • Saline
    • Vancomycin
    Sweden

  • Study on Early Use of Vasopressin and Norepinephrine for Patients with Septic Shock

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Septic shock
    Investigated Drugs:
    • Sulfur Hexafluoride
    • Argipressin
    Italy

  • Study on Preventing Infections After Esophageal Cancer Surgery Using Colistin Sulfate, Tobramycin, and Amphotericin B in Patients with Resectable Esophageal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Oesophageal carcinoma
    Investigated Drugs:
    • Nystatin
    • Tobramycin
    • Colistin Sulfate
    Belgium The Netherlands

  • Study on the Effectiveness of Moxifloxacin and Drug Combination for Treating Bone Implant Infections in Patients with Long Bone Fractures

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ampicillin
    • Cefazolin
    • Cefepime
    Spain

  • Study Comparing Meropenem and Piperacillin/Tazobactam for Adults with Sepsis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Sepsis
    • Septic shock
    Investigated Drugs:
    • Linezolid
    • Piperacillin Sodium
    • Tazobactam Sodium
    Denmark Sweden

  • Study on Inhaled Levofloxacin and Sodium Chloride for Patients with Community-Acquired Pneumonia, Including Those with Pre-existing Lung Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Levofloxacin
    • Sodium Chloride
    Denmark
Previous Page
1 … 14 15 16 17 18 … 46
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!